Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ: PPHMP), announced that its Board of Directors has declared a quarterly cash dividend on the Company’s 10.50% Series E Convertible Preferred Stock (the “Series E Preferred Stock”). The quarterly dividend on the Series E Preferred Stock is payable on April 1, 2014 to holders of record at the close of business on March 21, 2014.
Peregrine Pharmaceuticals (NASDAQ:PPHM) stock opened at $2.59 in last session, and closed at $2.27, while the day range of Peregrine Pharmaceuticals (NASDAQ:PPHM) stock is $2.15 – $2.60. The stock showed a positive weekly performance of 18.85%.
Organovo Holdings, Inc. (NYSEMKT:ONVO), formerly Real Estate Restoration & Rental, Inc., is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. Organovo Holdings Inc. (NYSEMKT:ONVO) stock opened at $8.94 in last session, and closed at $8.61 by losing -6.92%. The 52 week range of $3.27 – $13.65. Company’s market capitalization is $665.00 million.
XOMA Corp logo XOMA Corp (NASDAQ:XOMA) was downgraded by stock analysts at MLV & Co. from a “buy” rating to a “hold” rating in a report issued on Tuesday, Analyst Ratings Net reports. XOMA Corp (NASDAQ:XOMA) stock decreased -8.71% and finished the last session at $5.87. The EPS of the stock remained -1.38. Company’s market capitalization is $557.93 million.
Sunshine Heart, Inc. (NASDAQ:SSH) on 11 march announced its financial results and provided a corporate update for the fourth quarter and full-year ended December 31, 2013. Sunshine Heart Inc. (NASDAQ:SSH) stock opened the session at $7.19, and closed the session at $6.26. The 52 week range of the Sunshine Heart Inc. (NASDAQ:SSH) stock remained $4.85 – $13.80 and the day range was $6.20 – $7.70.